R&D Pipeline

Pipeline (2021-2030)

Respiratory - Gene & Nucleic acids (2)

Modality Indication Targets Stage Company Project No. Detail
1 Development of a Lung-Selective RNA Therapeutic Candidate for lung fibrosis
Gene & Nucleic acids IPF **** Candidate Samyang Biopharm RS-2025-25448962
2 ASO-Based Therapeutics Targeting ATX for Pulmonary Fibrosis
Gene & Nucleic acids Pulmonary fibrosis ATX (autotaxin) Hit Sookmyung Women's University RS-2025-02213647